Gilead paying $5.1 billion to increase its stake in Belgian biotech Galapagos
July 14, 2019 at 17:01 PM EDT
Gilead Sciences Inc. will pay $5.1 billion to boost its stake in Galapagos NV and gain rights outside Europe to the Belgian biotechnology company’s treatments in development, in a broad research collaboration aimed at increasing growth at the drugmakers.